Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations
Abstract The U.S. Food and Drug Administration (FDA) emphasizes drug product development by Quality by Design (QbD). Critical material attributes (CMAs) are a QbD element that has an impact on pharmaceutical operations and product quality. Pharmaceutical drugs often crystallize as nee...
Hlavní autoři: | , , , , , , , |
---|---|
Další autoři: | |
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Springer International Publishing
2021
|
On-line přístup: | https://hdl.handle.net/1721.1/132086 |